Department of Gynaecology and Obstetrics, Odense University Hospital, J. B. Winsløws Vej 4, 5000 Odense C, Denmark; OPEN, Odense Patient Data Explorative Network, Odense University Hospital, B. Winsløws Vej 9 A, 5000 Odense C, Denmark; Department of Clinical Health, Faculty of Health Sciences, Clinical Institute, University of Southern Denmark, J.B. Winsløws Vej 19, 5000 Odense C, Denmark.
Department of Clinical Health, Faculty of Health Sciences, Clinical Institute, University of Southern Denmark, J.B. Winsløws Vej 19, 5000 Odense C, Denmark; Department of Pelvic Cancer, Karolinska University Hospital and Karolinska Institute, SE-171 77 Stockholm, Sweden.
Eur J Cancer. 2019 Mar;109:1-11. doi: 10.1016/j.ejca.2018.12.004. Epub 2019 Jan 14.
The purpose of the study was to evaluate the association between a nationwide introduction of robotic minimally invasive surgery (RMIS) and survival in women with early-stage endometrial cancer.
Prospective data on consecutive women with early-stage endometrial cancer who underwent surgery during January 2005 to June 2015 in Denmark were identified in the nationwide Danish Gynaecological Cancer Database. Data were linked with national registries regarding comorbidity, education, income and death. The cohort was divided according to the time they underwent surgery: Group 1 before RMIS introduction in their respective region and Group 2 after RMIS introduction. Five-year overall survival was compared by multivariate Cox proportional hazards models stratified by histopathological risk between Groups 1 and 2 and between surgical modalities within Group 2: total abdominal hysterectomy (TAH), laparoscopic minimally invasive surgery (LMIS) and RMIS.
Women in Group 1 (N = 3091) had significantly lower overall survival compared with those in Group 2 (N = 2563; hazard ratio [HR], 1.22; 95% confidence interval [CI], 1.05-1.42). Age, smoking, socioeconomic status, American Society of Anaesthesiologists (ASA) score, comorbidity and histopathological risk influenced the overall survival. Following RMIS adoption, TAH was associated with higher mortality compared with LMIS and RMIS (HR, 1.42; 95% CI 1.02-1.97 and HR, 1.70; 95% CI 1.31-2.19 for LMIS and RMIS, respectively). There was no significant survival difference between RMIS and LMIS (HR, 1.19; 95% CI 0.85-1.68).
The national introduction of robotic surgery for early-stage endometrial cancer was associated with improved survival irrespective of age, body mass index, ASA score, comorbidity, smoking, socioeconomic status and histopathological risk.
本研究旨在评估在丹麦全国范围内引入机器人微创手术(RMIS)与早期子宫内膜癌患者生存之间的关联。
在丹麦全国妇科癌症数据库中,确定了 2005 年 1 月至 2015 年 6 月期间连续接受手术治疗的早期子宫内膜癌女性的前瞻性数据。这些数据与关于合并症、教育程度、收入和死亡的国家登记处相关联。该队列根据手术时间分为两组:第一组为所在地区 RMIS 引入前,第二组为 RMIS 引入后。通过多变量 Cox 比例风险模型比较两组间和第二组内手术方式间(全子宫切除术、腹腔镜微创手术和 RMIS)的 5 年总生存率,分层依据组织病理学风险。
与第二组(n=2563)相比,第一组(n=3091)的患者总生存率显著降低(风险比 [HR],1.22;95%置信区间 [CI],1.05-1.42)。年龄、吸烟、社会经济地位、美国麻醉医师协会(ASA)评分、合并症和组织病理学风险均影响总生存率。RMIS 引入后,与 LMIS 和 RMIS 相比,TAH 与更高的死亡率相关(HR,1.42;95%CI 1.02-1.97 和 HR,1.70;95%CI 1.31-2.19,分别用于 LMIS 和 RMIS)。RMIS 和 LMIS 之间的生存率无显著差异(HR,1.19;95%CI 0.85-1.68)。
无论年龄、体重指数、ASA 评分、合并症、吸烟、社会经济地位和组织病理学风险如何,在丹麦全国范围内引入机器人手术治疗早期子宫内膜癌均与生存改善相关。